...
首页> 外文期刊>Cell transplantation >Intramyocardially Transplanted Neonatal Cardiomyocytes (NCMs) Show Structural and Electrophysiological Maturation and Integration and Dose-Dependently Stabilize Function of Infarcted Rat Hearts
【24h】

Intramyocardially Transplanted Neonatal Cardiomyocytes (NCMs) Show Structural and Electrophysiological Maturation and Integration and Dose-Dependently Stabilize Function of Infarcted Rat Hearts

机译:肌内移植的新生儿心肌细胞(NCMS)显示结构和电生理成熟和整合和剂量依赖性稳定梗塞大鼠心脏的功能

获取原文
获取原文并翻译 | 示例

摘要

Cardiac cell replacement therapy is a promising therapy to improve cardiac function in heart failure. Persistence, structural and functional maturation, and integration of transplanted cardiomyocytes into recipients' hearts are crucial for a safe and efficient replacement of lost cells. We studied histology, electrophysiology, and quantity of intramyocardially transplanted rat neonatal cardiomyocytes (NCMs) and performed a detailed functional study with repeated invasive (pressure volume catheter) and noninvasive (echocardiography) analyses of infarcted female rat hearts including pharmacological stress before and 3 weeks after intramyocardial injection of 5 x 10(6) (low NCM) or 25 x 10(6) (high NCM) syngeneic male NCMs or medium as placebo (Ctrl). Quantitative real-time polymerase chain reaction (PCR) for Y-chromosome confirmed a fivefold higher persisting male cell number in high NCM versus low NCM after 3 weeks. Sharp electrode measurements within viable slices of recipient hearts demonstrated that transplanted NCMs integrate into host myocardium and mature to an almost adult phenotype, which might be facilitated through gap junctions between host myocardium and transplanted NCMs as indicated by connexin43 in histology. Ejection fraction of recipient hearts was severely impaired after ligation of left anterior descending (LAD; pressure volume catheter: 39.2 +/- 3.6%, echocardiography: 39.9 +/- 1.4%). Repeated analyses revealed a significant further decline within 3 weeks in Ctrl and a dose-dependent stabilization in cell-treated groups. Consistently, stabilized cardiac function/morphology in cell-treated groups was seen in stroke volume, cardiac output, ventricle length, and wall thickness. Our findings confirm that cardiac cell replacement is a promising therapy for ischemic heart disease since immature cardiomyocytes persist, integrate, and mature after intramyocardial transplantation, and they dose-dependently stabilize cardiac function after myocardial infarction.
机译:心肌细胞替代疗法是改善心力衰竭患者心功能的一种有前途的治疗方法。持久性、结构和功能成熟,以及移植心肌细胞与受体心脏的整合,对于安全有效地替换丢失的细胞至关重要。我们研究了组织学,电生理学,以及心肌内移植的大鼠新生心肌细胞(NCM)的数量,并对梗死雌性大鼠心脏进行了详细的功能研究,包括心肌内注射5x10(6)(低NCM)或25x10(6)(高NCM)同基因雄性大鼠前和3周后的药物应激NCMs或中剂量安慰剂(Ctrl)。对Y染色体进行定量实时聚合酶链反应(PCR)证实,3周后,高NCM患者的持续男性细胞数是低NCM患者的五倍。在受体心脏的活切片中进行的锐利电极测量表明,移植的NCM整合到宿主心肌中,并成熟到几乎成年的表型,这可能是通过宿主心肌和移植的NCM之间的缝隙连接促进的,如组织学上的连接蛋白43所示。结扎左前降支后受体心脏的射血分数严重受损(LAD;压力容量导管:39.2+/-3.6%,超声心动图:39.9+/-1.4%)。重复分析显示,Ctrl在3周内进一步显著下降,而细胞治疗组则呈剂量依赖性稳定。细胞治疗组的卒中量、心输出量、心室长度和室壁厚度始终保持稳定的心功能/形态。我们的研究结果证实,心肌细胞置换术是治疗缺血性心脏病的一种有前途的方法,因为心肌移植后未成熟心肌细胞持续存在、整合和成熟,并且心肌梗死后心肌细胞的数量依赖性稳定心功能。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号